Login / Signup

Adverse events and complications after magnetic resonance-guided focused ultrasound (MRgFUS) therapy in uterine fibroids - a systematic review and future perspectives.

Magdalena ZgliczyńskaTomasz LozinskiMagdalena ZgliczyńskaMaciej ByrczakSalvatore Giovanni VitaleMaciej SkrzypczakKornelia Teresa ZarębaMichal Ciebiera
Published in: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group (2023)
MRgFUS seems to be safe in UF therapy. The occurrence of AEs, especially major ones, is relatively low in comparison with other methods. The new devices and more experience of their users seem to reduce AE rate. The lack of unification in AE reporting and missing data are the main issues in this area. More prospective, randomized studies with unified reporting and long follow-up are needed to determine the safety in a long-term perspective.
Keyphrases
  • magnetic resonance
  • adverse drug
  • risk assessment
  • double blind
  • open label
  • clinical trial
  • computed tomography
  • placebo controlled
  • stem cells
  • magnetic resonance imaging
  • big data
  • phase ii
  • cell therapy
  • study protocol